No validated dosing, pharmacokinetics, or long-term safety There is no human pharmacokinetic data for injectable BPC-157: How long it lasts in the body What tissues it reaches Whether it accumulates How it is metabolized or excreted Long-term risks cannot be assessed without such information
Tiredness / lethargy Depression Hair loss Pins & needles Numbness in the hands or feet Tremors or palsies Palpitations Recurrent headaches Dizziness Slower digestion / weight gain Irritability Mood swings Confusion Forgetfulness Fogginess Psychosis Hallucinations or delusion Anxiety/Panic attacks Onset of dementia Hormonal imbalances or worsened menopause symptoms What are contra-indications to having Vitamin B12 intramuscular injections
Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues
Patients often ask about BPC-157 or TB-500 when they are struggling with recovery, inflammation, physical stress, or performance-related concerns
Frequency depends on your treatment goals
Tirzepatide and B12 work through different mechanisms and do not have known harmful interactions